Development of an Ingestible Expandable Capsule for Weight Loss

Author:

Liu Xingyu,Wu Yeung,Liu Chang,Chen Kaiqi,Gregersen Hans

Abstract

Obesity has grown to epidemic proportions with 2.1 billion people being overweight worldwide. A food-grade expandable capsule named EndoXpand for the treatment of overweight people was designed and developed in this study. EndoXpand consists of an inner expandable material (core), an embracing membrane, and a gelatin capsule shell. It is designed to occupy volume in the stomach and reduce hunger sensation. The occupied volume is changeable over time, dependent on the number of ingested capsules and their degradation time. This will avoid gastric accommodation to constant volume devices as seen in the use of intragastric balloons. Several materials were tested. Collagen casing was selected as the membrane and corn silk was used to tie the membrane. Dried black fungus (Auricularia auricula) was the biological material that expanded most. However, synthesized cellulose-based hydrogel expanded more and was chosen as the optimal expandable core material. The hydrogel-based EndoXpand expanded 72 times after soaking in an acidic environment for 80 min. The corn silk ligations weakened and broke after 3 h. This resulted in release of the expanded material that was designed to easily pass the pylorus and travel down the intestine for digestion or excretion. In conclusion, this study provides design and in vitro proof-of-technology data for a potential groundbreaking approach. Further studies are needed in animal models and human phase I studies.

Funder

internal funding of the Chinese University of Hong Kong, the Doctoral Scientific Research Foundation of Chongqing Normal University

Science and Technology Research Program of Chongqing Municipal Education Commission

Publisher

MDPI AG

Subject

Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health

Reference24 articles.

1. WHO (2000). Obesity: Preventing and Managing the Global Epidemic: Report of a WHO Consultation, WHO. Available online: https://apps.who.int/iris/handle/10665/42330.

2. Alsareii, S.A., Shaf, A., Ali, T., Zafar, M., Alamri, A.M., AlAsmari, M.Y., Irfan, M., and Awais, M. (2022). IoT framework for a decision-making system of obesity and overweight extrapolation among children, youths, and adults. Life, 12.

3. Why primary obesity is a disease?;Gratteri;J. Transl. Med.,2019

4. National Clinical Guideline Centre (UK) (2014). Obesity: Identification, Assessment and Management of Overweight and Obesity in Children, Young People and Adults, National Institute for Health and Care Excellence.

5. Antiobesity pharmacotherapy: New drugs and emerging targets;Kim;Clin. Pharmacol. Ther.,2014

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3